Sources | Names Used |
---|---|
CTRPv2 | BRD-A05715709 |
PharmacoGx | BRD-A05715709 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C1orf216 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
mRNA | CTD-2583A14.9 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
mRNA | PPRC1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
mRNA | LRRC4B | CTRPv2 | pan-cancer | AAC | -0.11 | 0.09 |
mRNA | POLR3D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.09 |
mRNA | VTA1 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.09 |
mRNA | SF3B6 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.09 |
mRNA | RBL2 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.09 |
mRNA | HLA-DMB | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
mRNA | NCOA1 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.09 |